ASMB
NASDAQ · Biotechnology
Assembly Biosciences Inc
$20.42
+0.42 (+2.10%)
Open$20.00
Previous Close$20.00
Day High$21.10
Day Low$20.00
52W High$39.71
52W Low$19.20
Volume—
Avg Volume188.1K
Market Cap424.31M
P/E Ratio—
EPS$-0.16
SectorBiotechnology
Analyst Ratings
Strong Buy
11 analysts
Price Target
-46.5% upside
Current
$20.42
$20.42
Target
$10.92
$10.92
$9.01
$10.92 avg
$17.95
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 134.01M | 44.93M | 300.07M |
| Net Income | -11,347,616 | -56,963,075 | 8.49M |
| Profit Margin | -8.5% | -133.8% | 2.8% |
| EBITDA | -22,221,462 | -67,781,254 | 15.38M |
| Free Cash Flow | — | — | 12.77M |
| Rev Growth | — | +65.8% | +3.4% |
| Debt/Equity | — | — | 0.84 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |